Analgesic abuse and psychiatric comorbidity in headache patients;Abus d'antalgiques et comorbidité psychiatrique chez les céphalalgiques

Encephale

Volumn 28, Issue 5 I, 2002, Pages 466-471

  Radat, F ^a   Irachabal, S ^a   Swendsen, J ^a   Henry, P ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Abuse; Addiction; Comorbidity; Headache; Migraine; Psychiatric disorders

Indexed keywords

ANALGESIC AGENT;

ANALGESIC AGENT ABUSE; ANXIETY DISORDER; CHRONIC PAIN; CHRONICITY; CLINICAL FEATURE; COMORBIDITY; DISEASE CLASSIFICATION; DRUG DEPENDENCE; DRUG WITHDRAWAL; HEADACHE; HOME CARE; HOSPITALIZATION; HUMAN; MALADJUSTMENT; MENTAL DISEASE; MIGRAINE; NEUROSIS; PANIC; PASSIVE AVOIDANCE; PERSONALITY DISORDER; PHOBIA; REVIEW;

ANALGESICS; HUMANS; MIGRAINE DISORDERS; PERSONALITY DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 0036756461     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM IV, 1994, 4th Ed. Washington D C: American Psychiatric Association.
2. Berndt S, Maier C, Schutz HW. Polymedication and medication compliance in patients with chronic non-malignant pain. Pain 1993; 52: 331-9.
3. Bouland-Predseil P, Corand V, Henry P. Céphalées medicamenteuses. Aspects cliniques et épidémiologiques. Éditions du GRECS: Colloque de Dijon 1994: 81-90.
4. Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: A prospective epidemiologic study in young adults. J Psychiatr Res 1993; 27: 211-21.
5. Brown RL, Patterson JJ, Rounds LA et al. Substance abuse among patients with chronic back pain. J Fam Pract 1996; 43,21: 152-60.
6. Castillo J, Munoz P, Guitera V et al. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-6.
7. Chaturvedi SK. Family morbidity in chronic pain patients. Pain 1987; 30:159-68.
8. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and caracter. Arch Gen Psychiatry 1993; 50: 975-90.
9. Compton P, Darakjian J, Miotto K. Screening addiction in patients with chronic pain and « problematic » substance use: Evaluation of a pilot assessment tool. J Pain Management 1998; 16,6: 355-63.
10. Curioso EP, Young WB, Shechter AL et al. Psychiatric comorbidity predicts outcome in chronic daily headache patients. Neurology 1999; 52: A 471.
11. Diener HC, Dahlof CGH. Headaches associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. Headaches lind New York: Raven Press Ldt, 2000: 721-7.
12. Evers S, Gralow I, Bauer B et al. Sumatriptan and ergotamine overuse and drug-induced headache: A clinicoepidemiologic study. Clin Neuropharmacol 1999; 22,4: 201-6.
13. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependance and addiction in chronic pain patients. Clin J Pain 1992; 8, 2: 77-85.
14. Headache Classification Committee Of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7):1-96.
15. Jensen MP, Karoly P. Control beliefs, coping efforts and adjustment to chronic pain. J Consult Clini Psychol 1991; 59, 3: 431-8.
16. Jensen MP, Karoly P. Pain specific beliefs, perceived symptoms severity and adjustment to chronic pain. Clin J Pain 1992; 8:123-30.
17. Katon W, Egan K, Miller D. Chronic pain: Lifetime psychiatric diagnoses and family history. Am J Psychiatry 1985; 142, 10: 1156-60.
18. Kouyanou K, Pither CE, Wessely S. Medication misuse, abuse and dependance in chronic pain patients. J Psychosom Res 1997; 43, 5: 497-504.
19. Kurman RG, Hursey KG, Mathew NT. Assessment of chronic refractory headache: The role of the MMPI 2. Headache 1992; 32: 432-5.
20. Lanteri-Minet M. Les céphalées par abus médicamenteux. Pathol. Biol 2000; 48: 707-14.
21. Lucas C, Lanteri-Minet M, Leroy L. FRAMIG 1999 (111). Comportements thérapeutiques des migraineux. Rev Neurol 2000; 156 (Suppl 1): S1, 134.
22. Merikangas KR, Mehta RL, Olnar BE. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addict Behav 1998; 23, 6: 893-907.
23. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: Analysis of factors. Headache 1982; 22: 66-8.
24. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27: 102-6.
25. Mathew NT, Kurman RK, Perez F. Drug Induced headache, clinical features and management. Headache 1990; 30: 634-8.
26. Michultka DM, Blanchard EB, Appelbaum et al. The refractory headache patient. II. High medication consumption (analgesic rebound) headache. Behav Res Ther 1989; 27: 411-20.
27. Miotto K, Compton P, Ling W et al. Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996; 37:223-35.
28. Mitsikostas DD, Thomas AM. Comorbidity of headache and depressive disorders. Cephalalgia 1999; 19: 207-11.
29. Portenoy RK. Opioid therapy for chronic non malignant pain: A review of the critical issues. Journal of Pain and Symptom Management 1996; 11, 4: 203-217.
30. Radat F, Sakh D, Lutz G. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 1999; 39: 477-80.
31. Romach M, Busto U, Somer G et al. Clinical aspects of chronic use of alprazolam and lorazepam. Am J Psychiatry 1995; 152, 8: 1161-7.
32. Saper JR, Jones JM. Ergotamine tartrate dependency: Features and possible mecanisms. Clin Neuropharmacol 1986; 9, 3:244-56.
33. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13: 227-83.
34. Siniatchin M, Riabus M, Hasenbring M. Coping styles of headache sufferers. Cephalalgia 1999; 19: 165-75.
35. Sproule BA, Busto UE, Somer G et al. Caracteristics of dependant and non dependant regular users of codeine. J Clin Psychopharmacol 1999; 19: 367-72.
36. Verri AP, Projetti Cecchini A, Galli C et al. Psychiatric comorbidity in chronic daily headache. Cephalalgia 1998; 18 (Suppl 1): 45-9.
37. Wang W, Timsit-Berthier M, Schoenen J. Negative correlation between sensation seeking behavior and intensity dependence of auditory evoked potentials in migraine. Cephalalgia 1995; 15 (Suppl 14): 65.
38. Zed PJ, Loewen PS, Robinson G. Medication-induced headache: Overview and systematic review of the therapeutic approaches. Ann Pharmacother 1999; 33: 61-72.